🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What is the STEMI equivalent in #CardioOnc? Javid Moslehi Nicolas Palaskas, MD Eric H Yang, MD @DLenihanICOS_MD Dipti Gupta MD, MPH Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC jean-bernard durand Elie Mouhayar R.R. Baliga, MD Brenton Bauer Kibar Yared

When at UT Austin, do as the Longhorns do #FallonAtUT

Watch to learn how a type of #immunotherapy called checkpoint blockade inhibitors work to treat cancer. #CancerMoonshot #SITC2019 #endcancer

Ciao! Going to 🇮🇹 for a #CardioOnc meeting. Excited to meet our fellow Italian CardioOncologists

Some of our excellent faculty Elie Mouhayar Nicolas Palaskas, MD will be there representing with me MD Anderson Cancer Center & my good friend Javid Moslehi will be there.

Superb talk by our Elie Mouhayar from MD Anderson Cancer Center presenting data on a recent prospective clinical trial on cardiac rehabilitation in patients that developed clinical HF related to chemotherapy. Here is the paper 👉🏼insights.ovid.com/crossref?an=01… #CardioOnc

Excellent and engaging discussion of the role of social media and benefit of twitorials by Dr J Lopez Juan Lopez-Mattei, MD MD Anderson Cancer Center

Excellent review of what is needed to establish Cardioncology clinic by Dr Jahangir Eiman and his experience at Vanderbilt Juan Lopez-Mattei, MD MD Anderson Cancer Center Nicolas Palaskas, MD Javid Moslehi

Very informative presentation with Practical approach at managing CV risks and CVD in patients with prostate cancer treated with androgen deprivation by Dr. Jahangir ⁦Juan Lopez-Mattei, MD⁩ ⁦Javid Moslehi⁩

All what you need to know about the role of CMR in Cardioncology by Dr Juan Lopez ⁦Juan Lopez-Mattei, MD⁩ ⁦MD Anderson Cancer Center⁩ ⁦Javid Moslehi⁩

Cezar Iliescu Wamique Yusuf Elie Mouhayar @djtweardy Hani Jneid MD Umair Khalid Peter WT Pisters, MD Susan C Gilchrist, MD, MS Ana Barac, MD, PhD, FACC, FAHA GOliveiraMD Joerg Herrmann Eric H Yang, MD Salim S. Hayek, MD

COVID-19: STATISTICS WARN OF A WORSENING TREND IF RISKS NOT MANAGED blog.bakerinstitute.org/2020/03/24/cov…

Had the honor of doing 1st STEMI case in a pt with suspected COVID at our institution today. Sick, requiring intubation in cath lab. 1.-I felt peaceful knowing we were well prepared & protected. If I get infected, then nothing can stop this virus, were as protected as can be. 1/

Sharing this campaign is a meaningful way to raise awareness with your friends and family. Public Good impact.publicgood.com/campaign/e2004…

Way to go Nic. Congratulations

👉👉👉Delighted to share our #CardioOnc collaborative multi-disciplinary work led by Elie Mouhayar & Danielle Hammond, MD @jaccjournals jacc.org/doi/10.1016/j.… | An important clinical topic: Successful 👏🏽 Reversible myocardial edema in patient with #Tagraxofusp-induced #CLS | #BPDCN

#BPDCN 👉👉👉 Reversible Myocardial Edema Secondary to #Tagraxofusp-Induced Capillary... sciencedirect.com/science/articl… | #CLS #BPDCN Elie Mouhayar Danielle Hammond, MD Naveen Pemmaraju, MD Juan Lopez-Mattei, MD Marina Konopleva | JACC Journals #CardioOnc #JACCCaseReports

A new US randomized trial has failed to show benefit of a 35-day course of oral anticoagulation with rivaroxaban for the prevention of thrombotic events in outpatients with symptomatic COVID-19. #AHA22 ms.spr.ly/6016dSiya

Excellent team effort & execution of a brilliant idea. Congratulations !